- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
FDA Issues Warning About Thermography
Thermography not a replacement for mammography
The Food and Drug Administration (FDA) today released a consumer warning that thermography should not be used in place of mammography for breast cancer screening or diagnosis.
The FDA says mammography- an X-ray of the breast-is still the most effective way of detecting breast cancer in its earliest stages. The wanring does not mention digital mammogrpahy or other modalities.
While thermography is cleared by FDA for use as an adjunct, or additional tool, it should not be used by itself to screen for, or diagnose, breast cancer, the agency clarifies.
Learn more about the FDA's concerns about the use of thermography as a screening tool at
http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm257499.htm
Mammography News: FDA Grants Expanded 510(k) Clearance for AI-Powered SmartMammo Dx DBT Software
November 29th 2024Originally cleared by the FDA in 2021, the SmartMammo Dx software for digital breast tomosynthesis (DBT) can now be utilized with the Senographe Pristina mammography systems from GE HealthCare.
